Maximizing the benefits of GLP-1 medications through personal health coaching

Toronto — October 3, 2024 — NexJ Health Inc. (“NexJ Health”), provider of polychronic condition management and mental wellbeing solutions, is providing personalized health coaching for patients on GLP-1 Agonists in an innovative program called Empower. Designed to support in managing health and maximizing treatment outcomes, Empower leverages NexJ Health’s expertise in digital health solutions and personalized coaching to address the unique challenges faced by patients taking GLP-1 agonist medications.

Since its launch, Empower has already demonstrated transformative results as shown with a patient who faced severe gastrointestinal issues, leading to an ER visit. Their health coach supported them in making the necessary adjustments to diet, developed a strength-training exercise regimen, and provided personalized guidance to manage Ozempic’s side effects. As a result of this comprehensive approach, the patient successfully adhered to her Ozempic treatment, achieving weight loss goals and diabetes management, and enhanced overall quality of life. “I needed a complete lifestyle change. I wasn’t given enough guidance on how to manage all the effects of the medicine, and my trip to the ER scared me straight. Working with my health coach has made a significant difference.”

Key features of the NexJ Empower GLP-1 Program include:

  • Personalized coaching using evidence-based protocols targeted to the needs of patients taking GLP-1 medicines
  • Goal setting support and evidence-based education to maximize medication effectiveness and reduce the risk of chronic disease
  • Digital tools for tracking progress and monitoring trends with expert guidance

“We are excited to share the outstanding results of this specialized program designed to support patients on GLP-1 agonist medications,” said Daniela Liggio, President of NexJ Health. “Empower marks another significant step in enabling patients to take control of their health, perfectly aligning with our mission to promote active patient engagement.”

The launch of Empower is in response to the growing use of GLP-1 agonist medications for conditions such as type 2 diabetes and obesity. The program addresses the need for comprehensive support to ensure patients can adhere to their treatment plans and make the necessary lifestyle adjustments.

For more information about this program, or to register, visit www.nexjhealth.com/glp1.

For media inquiries, please contact:
Email: info@nexjhealth.com
Phone: 416-227-3700
Web: www.nexjhealth.com

About NexJ Health Inc.
NexJ Health Inc. is a provider of patient-facing population health management solutions that deliver patient engagement for polychronic condition management and mental wellbeing. At NexJ Health, we believe that the most efficient and cost-effective way to offset the rise in chronic disease is to empower patients, with the support of their families, friends, and healthcare professionals, to actively participate in managing their own chronic condition(s). By engaging patients through NexJ Connected Wellness, we help to achieve healthcare’s quintuple aim: improve the patient experience, improve population health, lower the per capita cost of care, increase provider satisfaction, and deliver business efficiency. For more information about NexJ Health visit www.nexjhealth.com, email info@nexjhealth.com, or call 416-227-3700.